George Tidmarsh, the top drug regulator at the US Food and Drug Administration (FDA), has left the agency following claims in ...
The search continues for a new leader for the FDA’s Center for Drug Evaluation and Research after George Tidmarsh resigned on ...
The head of the FDA's drug division resigned while under internal investigation, saying he was pushed out after raising concerns.
On this week’s episode of "The Readout LOUD," melodrama at the top of the FDA and the latest on the Pfizer-Novo Nordisk ...
Medpage Today on MSN
Threat to Lung Cancer Advances; Underestimating Alcohol Risks; Warning on NCI Budget
Federal budget cuts pose a threat to progress that has improved lung cancer survival, according to the American Lung ...
Raw Story on MSNOpinion
Wall Street Journal bashes 'dysfunction' inside Trump's health agency
The Wall Street Journal's conservative editorial board bashed the "dysfunction" that appears to be hampering the Food and ...
I am calling for Dr. Vinay Prasad to manage the FDA in a mature, professional, competent, transparent manner. That’s just the bare minimum, and yet, he can’t even manage that.
In Episode 28, Miroslav Gasparek, Sensible; Lizzy Lawrence, STAT; and Joe Lewis, Deloitte, go behind the headlines.
Recursion announced Najat Khan, PhD, currently chief R&D and commercial officer and a board member, will succeed co-founder and CEO Chris Gibson, PhD as CEO and president. Khan will also continue in ...
Detailed price information for Aurinia Pharm Ord (AUPH-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback